NASDAQ •
Healthcare •
Biotechnology •
Quote as of 05/26/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1.7 mln
Float6.10 mln
Piotroski F-Score
1
/ 9
Very weak
Relative Strength
99
/ 100
Top performer
Debt / Equity
0.10
Very low leverage
ROE
-86.15
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Virax Biolabs Group Limited is a UK-based biotechnology company that develops and sells diagnostic test kits for detecting and managing viral diseases, covering areas such as respiratory illness, infectious diseases, fertility, cancer, and animal health. The company also offers a T cell diagnostic device paired with a wellness app, along with laboratory services including antibody engineering, vaccine testing, and custom protein work. It serves hospitals, research organizations, independent labs, and distributors across the United Kingdom, the United States, and China.
